European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision

作者:

DOI: 10.1111/J.1085-9489.2006.00059.X

关键词: Physical therapyTask forceMultifocal motor neuropathyMEDLINEMismatch negativityGuidelineSystematic reviewPhysical medicine and rehabilitationPeripheral nerveMedicineFirst revision

摘要: A European Federation of Neurological Societies/Peripheral Nerve Society consensus guideline on the definition, investigation, and treatment multifocal motor neuropathy (MMN) was published in 2006. The aim is to revise this guideline. Disease experts considered references retrieved from MEDLINE Cochrane Systematic Reviews between August 2004 July 2009 prepared statements that were agreed an iterative fashion. Task Force Good Practice Points define clinical electrophysiological diagnostic criteria for MMN, investigations be considered, principal recommendations

参考文章(109)
John J Kelly Jr, MD, Robert A Kyle, John M Miles, Peter C O'Brien, Peter James Dyck, The spectrum of peripheral neuropathy in myeloma Neurology. ,vol. 31, pp. 24- 24 ,(1981) , 10.1212/WNL.31.1.24
Gareth Parry, Motor neuropathy with multifocal conduction block. Seminars in Neurology. ,vol. 13, pp. 269- 275 ,(1993) , 10.1055/S-2008-1041134
Susanne Renaud, Michael Gregor, Peter Fuhr, Delia Lorenz, G�nther Deuschl, Alois Gratwohl, Andreas J. Steck, Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle & Nerve. ,vol. 27, pp. 611- 615 ,(2003) , 10.1002/MUS.10359
A. Pestronk, D. R. Cornblath, A. A. Ilyas, H. Baba, R. H. Quarles, J. W. Griffin, K. Alderson, R. N. Adams, A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Annals of Neurology. ,vol. 24, pp. 73- 78 ,(1988) , 10.1002/ANA.410240113
J. T. H. Van Asseldonk, L. H. Van den Berg, R. M. Van den Berg-Vos, G. H. Wieneke, J. H. J. Wokke, H. Franssen, Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain. ,vol. 126, pp. 186- 198 ,(2003) , 10.1093/BRAIN/AWG019
Robert A. Kyle, Steven P. Treon, Raymond Alexanian, Bart Barlogie, Magnus Björkholm, Madhav Dhodapkar, T.Andrew Lister, Giampaolo Merlini, Pierre Morel, Marvin Stone, Andrew R. Branagan, Véronique Leblond, Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia Seminars in Oncology. ,vol. 30, pp. 116- 120 ,(2003) , 10.1053/SONC.2003.50038
Raffaello Nemni, Giuseppe Santuccio, Elena Calabrese, Giuseppe Galardi, Nicola Canal, Efficacy of cyclosporine treatment in multifocal motor neuropathy. Journal of Neurology. ,vol. 250, pp. 1118- 1120 ,(2003) , 10.1007/S00415-003-0131-3
Margherita Capasso, Filomena Torrieri, Antonio Di Muzio, Maria Vittoria De Angelis, Alessandra Lugaresi, Antonino Uncini, Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? Clinical Neurophysiology. ,vol. 113, pp. 346- 353 ,(2002) , 10.1016/S1388-2457(02)00011-1
A Pestronk, J Florence, T Miller, R Choksi, MT Al-Lozi, TD Levine, Treatment of IgM antibody associated polyneuropathies using rituximab Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 74, pp. 485- 489 ,(2003) , 10.1136/JNNP.74.4.485